China Gains WHO PreQ For Circumcision Device, Flu Vaccine

China has obtained the first WHO prequalification for an innovative device for male circumcision, Shangring, along with a flu vaccine. Could the two high-profile recognitions in a month herald a new crop of high quality, made in China health products inching toward the world stage?

BEIJING – Whenever people talk about products that are made in China, there are generally no mentions of drugs, devices or biologics. That could change soon.

More from China

More from Focus On Asia

Sumitomo Offloads Asia Pharma Ops To Marubeni For $480m

 
• By 

The latest in a long line of restructuring measures will see Sumitomo Pharma making a stepped sale of its pharma operations in Asia to major Japanese trading house Marubeni.

How Big Pharma Is Redefining, Scaling India GCCs Amid Tech Advances

 

Senior executives from AstraZeneca, BMS, Novo Nordisk, Takeda and Regeneron outline how big pharma's global capability centers (GCCs) in India are evolving beyond cost efficiency, focusing on innovation, “agile experimentation” and new technology including GenAI, virtual & augmented reality, with some positioned as COEs. Will Indian multinationals use the GCC approach?

Asia Deal Watch: Dr. Reddy’s Gets Regional Rights To Pair Of Bio-Thera Biosimilars

 

Plus deals involving GV20/Mitsubishi Tanabe, Kaken/Alumis, AstraZeneca/Alteogen and deal terminations involving Clover/Gavi Alliance and Rhythm/RareStone.